Stability: BPC-157 is unusually stable for a peptide: it resists degradation in human gastric juice for 24+ hours, a property that underpins its oral bioavailability
Uncommon side effects include increased heart rate, acute pancreatitis, delayed gastric emptying, impaired renal function, acute kidney injury, worsening chronic renal failure and acute pancreatitis (fatal and non-fatal)
Posee mayor biodisponibilidad que la L-Carnitina y se destaca por sus propiedades cognitivas, mejorando las funciones cerebrales y contribuyendo a la prevencin de problemas neurolgicos y al fortalecimiento de la memoria
The STEP trials (semaglutide) showed 1522% body weight reduction over 68 weeks, while the SURMOUNT trials (tirzepatide) demonstrated up to 22% weight loss at the highest doses
"Todo este grupo de frmacos surgi inicialmente para el manejo del paciente con trastornos en el metabolismo glucmico
Female patients make up nearly 65% of GLP-1 users nationwide, and around 5.2% of women with obesity are prescribed a GLP-1 medication (compared to 4.2% of men)
